The evidence behind a federal plan to rollout COVID-19 vaccine booster shots to Americans beginning the week of Sept. 20, pending FDA review, has left some experts divided.
The evidence behind a federal plan to rollout COVID-19 vaccine booster shots to Americans beginning the week of Sept. 20, pending FDA review, has left some experts divided.
